Biotech / Finance

EC says separate GMP for cell and gene therapies is necessary

From in-PharmaTechnologist RSS
March 21, 2017 - 1:07am
The European Commission has rejected PIC/S criticism of a plan to develop GMP for advanced therapies and stressed that separate rules will not mean a lowering of standards.

Continue reading this article »